focus -WSS

focus

author：hotspot 2025-08-04 03:41:53 - browse：6755

Has PhRMA lost its fangs? Are 11th-hour changes ominous for clinical trials? And what’s next in pain medicine?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. The pharmaceutical industry, in court and in Congress, is working to water down legislation that will let Medicare negotiate certain drug prices. STAT Washington correspondent Rachel Cohrs joins us to explain the industry’s struggle to make headway — and how it factors into the 2024 election. We also discuss the latest news in the life sciences, including a twist in the future of Alnylam Pharmaceuticals, competition to Vertex Pharmaceuticals’ pain drug, and Gilead Sciences’ latest acquisition.

For more on what we cover, here’s all of Rachel’s coverage; here’s more on Vertex’s competition; here’s the news on Gilead; here’s where you can find episodes of Color Code; here’s where you can subscribe to the First Opinion Podcast; and here’s where you can subscribe to our biotech newsletter, The Readout.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Malaria cases in Florida and Texas: Here’s what you need to know
Next article： FDA approves Leqembi, a milestone in Alzheimer’s treatment

explore

hotspot

WSS

Flagship, Pfizer team up in deal worth up to $7 billion

Manchin plays down potential 3rd

FDA seeking to stop procedures at two unregulated stem cell clinics

Idaho college killings: Prosecutors dispute DNA could have been planted at murder scene

Neutralizing antibodies against HIV shows promise in children

How redistricting in 6 states could affect who controls Congress

knowledge

focus

entertainment

Drug repurposing or repositioning? The language matters

Biden administration sends mixed signals on US soldier who crossed into North Korea

BioMarin wins approval for gene therapy to treat hemophilia A

Zelenskyy on how Russian invasion may end, gratitude for US aid and Putin's weakness

New air purifier tech could be key to improving indoor air quality

Titanic submersible: What a 'catastrophic implosion' means and what officials found

Medical leaders decry Supreme Court decision on affirmative action

A look at other Americans who have crossed into North Korea over the years

Wildfire smoke exposes gaps in outdoor worker protections

Britain’s MI6 chief says his spies are using AI to disrupt flow of weapons to Russia

entertainment

Lack of darker skin in textbooks, journals harms patients of color

Vivek Ramaswamy, who's embraced Trump on the campaign trail, condemned him after Jan. 6

House passes resolution saying Israel isn't a 'racist or apartheid state'

With fresh data, a dynamic duo powers Eli Lilly to new heights

Titanic submersible: What a 'catastrophic implosion' means and what officials found

Masked men burn a market in a Mexican city plagued by gang violence, killing 9 people

explore

leisure time

hotspot

focus